Investing Profile

Brian Atwood(5)

VC

Photo of Brian Atwood, Versant Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Versant Ventures
13
$102.2M
CompanyStageDateRound SizeTotal Raised
Immune Design
Series COct 2013$49M
Series BJul 2010$32M
Series AJul 2008$18M
$99M
Veracyte
Series CJun 2013$28M
Series BJun 2010$28M
$71M
Co-investors: Brook Byers (Kleiner Perkins)
Five Prime Therapeutics
Private Equity RoundApr 2012$10M
Venture RoundFeb 2005$45M
$55M
Co-investors: Brook Byers (Kleiner Perkins)
OpGen
Series CMar 2012$17M
Series BSep 2010$17M
Venture RoundSep 2007$23.6M
$57.6M
Groove Biopharma
Series BDec 2011$6M
Series AApr 2010$3.9M
$9.9M
PhaseRx
Series AFeb 2008$20.2M
$20.2M